Secreted clusterin in colon tumor cell models and its potentialas diagnostic marker for colorectal cancer

Cancer Investigation

Volumn 30, Issue 1, 2012, Pages 72-78

  Rodrguez Pieiro, A M ^a   Garca Lorenzo, A ^a   Blanco Prieto, S ^a   Alvarez Chaver P ^a   Rodrguez Berrocal, F J ^a   Cadena, M Pez De La ^a   Martnez Zorzano, V S ^a  

^a UNIVERSITY OF VIGO   (Spain)

Author keywords

Caco 2; Clusterin; Colorectal cancer; SW 480; SW 620

Indexed keywords

CLUSTERIN; TUMOR MARKER;

ARTICLE; CANCER CELL; CARCINOGENESIS; CELL DIFFERENTIATION; COLORECTAL CANCER; CYTOPLASM; DOWN REGULATION; HUMAN; HUMAN CELL; LOCAL METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CACO-2 CELLS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CLUSTERIN; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; TUMOR MARKERS, BIOLOGICAL;

EID: 84855841230     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2011.630051     Document Type: Article

References (30)

1. Jones SE, Jomary C. Clusterin. Int J Biochem Cell Biol 2002;34:427-431.
2. Verbrugghe P, Kujala P,Waelput W, Peters P, Cuvelier CA. Clusterin in human gut-associated lymphoid tissue, tonsils, and adenoids: localization to M cells and follicular dendritic cells. Histochem Cell Biol 2008;129:311-320.
3. De Silva HV, Stuart WD, Park UB, Mao SJ, Gil CM, Wetterau JR, Busch SJ, Harmony JA. Purification and characterization of apolipoprotein J. J Biol Chem 1990;265:14292-14297.
4. Zhang H, Kim JK, Edwards CA, Xu Z, Taichman R, Wang CY. Clusterin inhibits apoptosis by interacting with activated Bax. Nat Cell Biol 2005;7:909-915. (Pubitemid 41486292)
5. Poon S, Treweek TM,Wilson MR, Easterbrook-Smith SB, Carver JA. Clusterin is an extracellular chaperone that specifically interacts with slowly aggregating proteins on their off-folding pathway. FEBS Lett 2002;513:259-266. (Pubitemid 34251275)
6. Leskov KS, Klokov DY, Li J, Kinsella TJ, Boothman DA. Synthesis and functional analyses of nuclear clusterin, a cell death protein. J Biol Chem 2003;278:11590-11600. (Pubitemid 36792721)
7. Shannan B, Seifert M, Leskov K, Willis J, Boothman D, Tilgen W, Reichrath J. Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer. CellDeath Differ 2006;13:12-19.
8. Pucci S, Bonanno E, Sesti F, Mazzarelli P, Mauriello A, Ricci F, Zoccai GB, Rulli F, Galatà G, Spagnoli LG. Clusterin in stool: a new biomarker for colon cancer screening? Am J Gastroenterol 2009;104:2807-2815.
9. Xie D, Sham JST, Zeng WF, Che LH, Zhang M, Wu HX, Lin, H-L, Wen J-M, Lau SH, Hu L, Guan X-Y. Oncogenic role of clusterin overexpression in multistage colorectal tumorigenesis and progression. World J Gastroenterol 2005;11:3285-3289. (Pubitemid 40973902)
10. Chen T, Turner J, McCarthy S, ScaltritiM, Bettuzi S, Yeatman TJ. Clusterin-mediated apoptosis is regulated by Adenomatous olyposis Coli and is p21 dependent but p53 independent. Cancer Res 2004;64:7412-7419. (Pubitemid 39372082)
11. Rodríguez-Piñeiro AM, Páez De La Cadena M, López-Saco A, Rodríguez-Berrocal FJ. Differential expression of serum clusterin isoforms in colorectal cancer. Mol Cell Proteomics 2006;5:1647-1657. (Pubitemid 44480392)
12. Rodríguez-Piñeiro, AM, Álvarez-Chaver P, Martínez-Zorzano VS, Rodríguez-Berrocal FJ, Páez de la Cadena M. Relevance of protein isoforms in proteomic studies. Current Proteomics 2007;4:235-252.
13. Hauck W, Stanners CP. Control of carcinoembryonic antigen gene family expression in a differentiating colon carcinoma cell line, Caco-2. Cancer Res 1991;51:3526-3533.
14. StierumR, Gasparia M, Dommels Y,Ouatas T, PlukH, Jespersen S, Vogels J, Verhoeckx K, Groten J, van Ommen B. Proteome analysis reveals novel proteins associated with proliferation and differentiation of the colorectal cancer cell line Caco-2. Biochim Biophys Acta 2003;1650:73-91. (Pubitemid 38234572)
15. Pinto M, Robine-Leon S, Appay MD, Kedinger M, Triadou N, Dussaulx E, Lacroix B, Simon-Assmann P, Haffen K, Fogh J, Zweibaum A. Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biol Cell 1983;47:323-330. (Pubitemid 14236699)
16. Merino-Trigo A, Rodríguez-Berrocal FJ, de Miguel E, Páez de la Cadena M. Activity and properties of alpha-L-fucosidase are dependent on the state of enterocytic differentiation of HT-29 colon cancer cells. Int J Biochem Cell Biol 2002;34:1291-1303. (Pubitemid 34804364)
17. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
18. Gornall AG, Bardawill CJ, David MM. Determination of serum proteins by means of the biuret reaction. J Biol Chem 1949;177:751-766.
19. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.
20. Rodríguez-Piñeiro AM, Ayude D, Rodríguez-Berrocal FJ, Páez de la Cadena M. Concanavalin-A chromatography coupled to twodimensional electrophoresis improves protein expression studies of the serum proteome. J Chromatogr B Analyt Technol Biomed Life Sci 2004;803:337-343.
21. Álvarez-Chaver P, Rodríguez-Piñeiro AM, Rodríguez-Berrocal FJ, Martínez-Zorzano VS, Páez de la Cadena M. Identification of hydrophobic proteins as biomarker candidates for colorectal cancer. Int J Biochem Cell Biol 2007;39:529-540. (Pubitemid 46096790)
22. Trougakos IP, Poulakou M, Stathatos M, Chalikia A, Melidonis A, Gonos ES. Serum levels of the senescence biomarker clusterin/ apolipoprotein J increase significantly in diabetes type II and during development of coronary heart disease or atmyocardial infarction. Exp Gerontol 2002;37:1175-1187. (Pubitemid 35418275)
23. Choi N, Tobe T, Hara K, Yoshida H, Tomita M. Sandwich ELISA assay for quantitativemeasurement of SP-40,40 in seminal plasma and serum. J Immunol Methods 1990;131:159-163. (Pubitemid 20241515)
24. Andersen CL, Schepeler T, Thorsen K, Birkenkamp-Demtroïder K,Mansilla F, Aaltonen LA, Laurberg S, Ørntoft TF. Clusterin expression in normal mucosa and colorectal cancer. Mol Cell Proteomics 2007;6:1039-1048.
25. Kevans D, Foley J, Tenniswood M, Sheahan K, Hyland J, O'Donoghue D, Mulcahy H, O'Sullivan J. High clusterin expression correlates with a poor outcome in stage II colorectal cancers. Cancer Epidemiol Biomarkers Prev 2009;18:393-399.
26. Peters WH, Roelofs HM. Time-dependent activity and expression of glutathione S-transferases in the human colon adenocarcinoma cell line Caco-2. Biochem J 1989;264:613-616. (Pubitemid 20024537)
27. Scaltriti M, Brausi M, Amorosi A, Caporali A, D'Arca D, Astancolle S, Corti A, Bettuzzi S. Clusterin (SGP-2, ApoJ) expression is down-regulated in low- and high-grade human prostate cancer. Int J Cancer 2004;108:23-30. (Pubitemid 37444439)
28. Katayama M, Nakano H, Ishiuchi A,Wu W, Oshima R, Sakurai J, Nishikawa H, Yamaguchi S, Otsubo T. Protein pattern difference in the colon cancer cell lines examined by two-dimensional differential in-gel electrophoresis and mass spectrometry. Surg Today 2006;36:1085-1093. (Pubitemid 44819452)
29. Mathias RA, Wang B, Ji H, Kapp EA, Moritz RL, Zhu HJ, Simpson RJ. Secretome-based proteomic profiling of Ras-transformed MDCK cells reveals extracellular modulators of epithelialmesenchymal transition. J Proteome Res 2009;8:2827-2837.
30. Pucci S, Bonanno E, Pichiorri F, Angeloni C, Spagnoli LG. Modulation of different clusterin isoforms in human colon tumorigenesis. Oncogene 2004;23:2298-2304 (Pubitemid 38496784)